Lymphedema Prevention Through Immediate Lymphatic Reconstruction (LILY) Trial
To learn if reconstruction of the lymphatic system at the time of axillary lymphadenectomy can reduce the risk of developing lymphedema.
• Participants diagnosed with IBC.
• Participants who have been scheduled for ILR/pLVB by their treating physician/surgeon at the time of their axillary lymphadenectomy for breast cancer
• Participants willing and able to comply with the study protocol requirements and all study-related visit requirements.
• Female subjects at least 18 years old and capable of providing consent to participate.
• Females of childbearing potential must have a negative urine pregnancy test within 36 hours prior to study drug administration and agree to use a medically accepted method of contraception for a period of one month following the study.